DEXRAZOXANE-REACH Reach Pharmaceuticals Pty Ltd
Product name
DEXRAZOXANE-REACH
Sponsor
Accepted date
Jan-2024
Active ingredients
dexrazoxane
Proposed indication
For cardiomyopathy associated with doxorubicin administration.
Application type
A (new medicine)
Publication date
Jan-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.